Schone Klinik Berchtesgadener Land
Schönau am Königssee, 83471, Germany
NCT Number: NCT06124625
Infection with SARS-CoV-2 virus leads to persistent symptoms for more than 12 weeks in 15% of cases ("post-COVID syndrome"). Symptoms like fatigue, dyspnoea, limitations in physical performance and activities, head ache, anxiety symptoms, and depression are heterogenous which limit physical health and participation in daily life activities.
In the last years, multidisciplinary rehabilitation programs showed benefits in quality of life and symptom intensity in patients with post-COVID. Therefore, rehabilitation programs are recommended for individuals with Post-COVID by official sites like the German Society of Pulmonology and the European Respiratory Society.
Own first data (published at the ERS conference 2023) revealed that one the one hand, inpatient rehabilitation is effective, however, on the other hand, it is challenging to maintain these effects after completing the program. Therefore, the aim of this study is to sustain these benefits by using a digital maintenance program following the rehabilitation program compared to usual care.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Schönau am Königssee, 83471, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week maintenance program (2 sessions per week à 90 minutes, digital and live). The multimodal programs consist of physiotherapy, training therapy, medical support, cognitive training, education and psychological support.
Individuals in this group undergo a 3-week inpatient rehabilitation program followed by a 12-week usual care period.
Time frame: Baseline, week 4, week 19
The scale of the physical and mental Health component summary score ranges from minimum 0 to maximum 100 points with higher scores indicating better quality of life
Time frame: Baseline, week 4, week 19
The number of COVID-symptoms will recorded as well as their intensity will be rated on a scale from 0 [not relevant] until 10 [very severe symptom].
Time frame: Baseline, week 4, week 19
following Parameters will be collected:Pimax
Time frame: Baseline, week 4, week 19
Fatigue Assessment Scale will be used
Time frame: Baseline, week 4, week 19
1-minute sit to stand test will be performed (maximum repetitions of squats in one minute)
Time frame: Baseline, week 4, week 19
Activity will be measure in steps per day using a wearable from Polar
Time frame: Baseline, week 4, week 19
EQ-5D-5L questionnaire will be used.
Time frame: Baseline, week 4, week 19
Frequency of therapeutical, medical and psychological sessions will be documented.
Time frame: Baseline, week 4, week 19
Amount and kind of medication will be documented.
Time frame: Baseline, week 4, week 19
Days of sickness will be documented.
Time frame: Baseline, week 4, week 19
Work ability index will be used
Time frame: Baseline, week 4, week 19
Indicators of rehabilitation status questionnaire (IRES-3) will be used.
Time frame: Baseline, week 4, week 19
Sleep quality will be assessed by using the Pittsburgh Sleep Quality Index (total score ranges from 0 to 21 with higher scores indicating higher impairment)
Time frame: Baseline, week 4, week 19
Patient Health Questionnaire 9 will be used. The total score ranges from 0 to 27 points with higher scores indicating worse Depression symptoms
Time frame: Baseline, week 4, week 19
Generalized Anxiety Disorder Scale 7 will be used. The total score ranges from 0 to 21 points with higher scores indicating more anxiety symptoms
Time frame: Baseline, week 4, week 19
Resilience scale RS-13 will be used.
Time frame: Baseline, week 4, week 19
Cognition will be measured via the software RehaCom (by Hasomed GmbH).
Time frame: Baseline, week 4, week 19
Cognitive impairment will be measured by Montreal Cognitive Assessment (MoCA)
Schön Klinik Berchtesgadener Land
Other
Effects of Rehabilitation Combined With a 12-week Maintenance Program Compared to Rehabilitation Alone in Post-COVID-19 - a Randomized, Controlled Trial.
Acronym: ReLoAd2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06231238
COVID-19, Chronic Disease
Camberwell, London, United Kingdom
View Trial DetailsNCT06042751
COVID-19, Chronic Disease
Hanover, Lower Saxony, Germany
View Trial DetailsNCT06073002
Behavior, COVID-19
Vienna, State of Vienna, Austria
View Trial DetailsNCT07545499
Behavior, COVID-19
Ankara, Altindağ, Turkey (Türkiye)
View Trial Details